Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
  1. 4 Shares withheld for taxes CEO gave up 4,535 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 23,590 shares (to pay taxes)
  3. 4 Grant or award CEO acquired 166,000 shares (grant or award)
  4. 4 Grant or award SVP, CHINA OPERATIONS acquired 29,000 shares (grant or award)
  5. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 52,000 shares (grant or award)
  6. 4 Shares withheld for taxes CEO gave up 23,490 shares (to pay taxes)
  7. 4 Shares withheld for taxes CEO gave up 819 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 16,658 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP, China Operations gave up 18,182 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO gave up 1,680 shares (to pay taxes)
  11. 4 Shares withheld for taxes CEO gave up 21,841 shares (to pay taxes)
  12. 4 Shares withheld for taxes Interim CEO gave up 819 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 1,807 shares (to pay taxes)
  14. 4 Shares withheld for taxes Interim CEO gave up 1,680 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,860 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP, China Operations gave up 3,308 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,085 shares (to pay taxes)
  18. 4 Planned sale Director sold 2,000 shares at $1.03 ($2,060)
  19. 4 Grant or award Chief Financial Officer acquired 120,000 shares (grant or award)
  20. 4 Grant or award SVP, China Operations acquired 120,000 shares (grant or award)

Page 4 of 38 · 760 filings